HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance

Publisher： MDPI

E-ISSN： 2072-6694|9|5|40-40

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.5, 2017-04, pp. : 40-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

By Dua Rajiv

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 685-697

Springer Publishing Company

Access to resources Recommend Favorite

Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options

Current Cancer Therapy Reviews, Vol. 11, Iss. 4, 2015-12 ,pp. : 269-291

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 151-162

Bentham Science Publishers

Access to resources Recommend Favorite

The 2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

By Shi Ming

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 351-362

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Trastuzumab in Metastatic Breast Cancer Overexpressing HER2

By McKeage K. Perry C.M.

American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. : 217-221

Adis International

Access to resources Recommend Favorite